Prahbat & Korukonda 201838
|
RET/ 185a
|
Mean oral NMP-SR dose:
271.4 mg for mean 18 weeks for unexplained RPL
262.5 mg for mean 19 weeks for cervical factor
311.1 mg for mean 10 weeks for threatened miscarriage (spotting or
prior history)
|
In all 185 cases, pregnancy was maintained to week 34 with no adverse
outcomes.
Two cases of spotting were managed symptomatically.
|